Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.740
-0.060 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
2.780
+0.040 (1.46%)
After-hours: Apr 28, 2026, 7:39 PM EDT
Altimmune Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Altimmune stock have an average target of 17.67, with a low estimate of 12 and a high estimate of 25. The average target predicts an increase of 544.89% from the current stock price of 2.74.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 16, 2026.
Analyst Ratings
The average analyst rating for Altimmune stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $25 | Strong Buy | Maintains | $12 → $25 | +812.41% | Mar 16, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +374.45% | Mar 6, 2026 |
| Citizens | Citizens | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +410.95% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +337.96% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +337.96% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
5.18K
from 41.00K
Decreased by -87.36%
Revenue Next Year
n/a
from 5.18K
EPS This Year
-1.14
from -1.00
EPS Next Year
-1.27
from -1.14
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 43,050 | n/a | ||||||
| Avg | 5,181 | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.0% | - | ||||||
| Avg | -87.4% | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.88 | -0.70 | ||||||
| Avg | -1.14 | -1.27 | ||||||
| Low | -1.64 | -1.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.